Tolerability of Transcutaneous Vagal Nerve Stimulation
ConditionStroke
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-21
SponsorThe University of Texas Health Science Center, Houston
About this trial
The purpose of this study is to assess the feasibility and tolerability of transcutaneous auricular vagus nerve stimulation (taVNS) in childhood stroke survivors undergoing bi-manual occupational therapy.
Eligibility criteria
Qualifiers
Childhood stroke survivor - either arterial ischemic stroke or intracerebral hemorrhage.
Stroke must be childhood onset, defined as occurring day 29 of life to 18 years of age (per the American Heart Association's definition of childhood stroke)
6 months or greater from stroke onset
Arm impairment, defined as pediatric stroke outcome measure of 1 or greater of affected arm.
Disqualifiers
Craniectomy without replacement of bone flap. Patients who underwent craniectomy will need the bone flap reattached prior to participation.
Presence of cranial metal implants or implant device that could be affected by taVNS: cochlear implant, implanted brain stimulator, or programmable ventriculoperitoneal shunt.
Trial design
Treatments tested in this trial
- transcutaneous auricular vagus nerve stimulation (taVNS)
Treatment groups
1 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov